Your browser doesn't support javascript.
loading
Otorhinolaryngological adverse effects of urological drugs
Maia, Nathalia de Paula Doyle; Lopes, Karen de Carvalho; Ganança, Fernando Freitas.
  • Maia, Nathalia de Paula Doyle; Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP. Programa de Pós-Graduação em Medicina, Otorrinolaringologia. São Paulo. BR
  • Lopes, Karen de Carvalho; Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP. Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço. São Paulo. BR
  • Ganança, Fernando Freitas; Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP. Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço. São Paulo. BR
Int. braz. j. urol ; 47(4): 747-752, Jul.-Aug. 2021. tab
Article in English | LILACS | ID: biblio-1286764
ABSTRACT
ABSTRACT

Purpose:

To describe the otorhinolaryngological adverse effects of the main drugs used in urological practice. Materials and

Methods:

A review of the scientific literature was performed using a combination of specific descriptors (side effect, adverse effect, scopolamine, sildenafil, tadalafil, vardenafil, oxybutynin, tolterodine, spironolactone, furosemide, hydrochlorothiazide, doxazosin, alfuzosin, terazosin, prazosin, tamsulosin, desmopressin) contained in publications until April 2020. Manuscripts written in English, Portuguese, and Spanish were manually selected from the title and abstract. The main drugs used in Urology were divided into five groups to describe their possible adverse effects alpha-blockers, anticholinergics, diuretics, hormones, and phosphodiesterase inhibitors.

Results:

The main drugs used in Urology may cause several otorhinolaryngological adverse effects. Dizziness was most common, but dry mouth, rhinitis, nasal congestion, epistaxis, hearing loss, tinnitus, and rhinorrhea were also reported and varies among drug classes.

Conclusions:

Most of the drugs used in urological practice have otorhinolaryngological adverse effects. Dizziness was most common, but dry mouth, rhinitis, nasal congestion, epistaxis, hearing loss, tinnitus, and rhinorrhea were also reported. Therefore, doctors must be aware of these adverse effects to improve adherence to the treatment and to minimize damage to the health of patients.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Prostatic Hyperplasia / Pharmaceutical Preparations Limits: Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2021 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Prostatic Hyperplasia / Pharmaceutical Preparations Limits: Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2021 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP/BR